PSYCHEDELIC NEWS

The Psychedelic Health Professionals Network provides accurate, up-to-date, research-based information about psychedelics.

News
A review of psychedelics trials completed in depression, informed by European regulatory perspectives
A review of psychedelics trials completed in depression, informed by European regulatory perspectives
Trippy hearing aids: Psychedelics spur new synapses in mouse ear cells
Trippy hearing aids: Psychedelics spur new synapses in mouse ear cells
Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
Tripping into treatment: Comparing initial and current motivations for psychedelic use
Tripping into treatment: Comparing initial and current motivations for psychedelic use
Associations between ayahuasca use in naturalistic settings and mental health and wellbeing outcomes: Analysis of a large global dataset
Associations between ayahuasca use in naturalistic settings and mental health and wellbeing outcomes: Analysis of a large global dataset
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences
A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences
Practitioner perspectives on meditation-based preparation for psychedelic experiences
Practitioner perspectives on meditation-based preparation for psychedelic experiences
Inside the quest to make “plant-based” MDMA
Inside the quest to make “plant-based” MDMA
Shrinking the know–do gap in psychedelic-assisted therapy
Shrinking the know–do gap in psychedelic-assisted therapy
Psychedelia's polarized views on RFK confirmation
Psychedelia's polarized views on RFK confirmation
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use
Tricycle Day interview with Imperial College researcher Tommaso Barba
Tricycle Day interview with Imperial College researcher Tommaso Barba
MDMA for active-duty troops: Aaron Wolfgang on DoD’s unprecedented study
MDMA for active-duty troops: Aaron Wolfgang on DoD’s unprecedented study
Setting the stage for the inner journey: Unraveling the interplay of contextual factors and the intensity of psychedelic-induced ego dissolution
Setting the stage for the inner journey: Unraveling the interplay of contextual factors and the intensity of psychedelic-induced ego dissolution
On minimizing risk and harm in the use of psychedelics
On minimizing risk and harm in the use of psychedelics
A qualitative analysis of the psychedelic mushroom come-up and come-down
A qualitative analysis of the psychedelic mushroom come-up and come-down
Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study
Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study
Psychedelic research recap January 2025
Psychedelic research recap January 2025
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Preliminary synthetic 5-MeO-DMT phase 2 results
Preliminary synthetic 5-MeO-DMT phase 2 results
Oregon’s emerging psilocybin services workforce: A survey of the first legal psilocybin facilitators and their training programs
Oregon’s emerging psilocybin services workforce: A survey of the first legal psilocybin facilitators and their training programs
Psychedelic futures and altered states in the religions of the ancient Mediterranean
Psychedelic futures and altered states in the religions of the ancient Mediterranean
MindMed announces first patient dosed in Panorama, the second pivotal phase 3 study of MM120 in generalized anxiety disorder
MindMed announces first patient dosed in Panorama, the second pivotal phase 3 study of MM120 in generalized anxiety disorder
An overview of currently active psychedelic research trials
An overview of currently active psychedelic research trials
FDA OKs esketamine nasal spray monotherapy for resistant depression
FDA OKs esketamine nasal spray monotherapy for resistant depression
American Journal of Bioethics, January edition
American Journal of Bioethics, January edition
Psilocybin-assisted group psychotherapy + mindfulness based stress reduction (MBSR) for frontline healthcare provider COVID-19 related depression and burnout: A randomized clinical trial
Psilocybin-assisted group psychotherapy + mindfulness based stress reduction (MBSR) for frontline healthcare provider COVID-19 related depression and burnout: A randomized clinical trial
An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment
An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment
Integration of personal psychedelic experiences into clinical practice: A phenomenological study in mental health professionals
Integration of personal psychedelic experiences into clinical practice: A phenomenological study in mental health professionals